NGNE
Price
$15.06
Change
-$0.38 (-2.46%)
Updated
Apr 24, 02:38 PM (EDT)
Capitalization
197.24M
NRXS
Price
$2.37
Change
-$0.05 (-2.07%)
Updated
Apr 24, 02:10 PM (EDT)
Capitalization
14.07M
27 days until earnings call
Ad is loading...

NGNE vs NRXS

Header iconNGNE vs NRXS Comparison
Open Charts NGNE vs NRXSBanner chart's image
Neurogene
Price$15.06
Change-$0.38 (-2.46%)
Volume$400
Capitalization197.24M
Neuraxis
Price$2.37
Change-$0.05 (-2.07%)
Volume$110
Capitalization14.07M
NGNE vs NRXS Comparison Chart
Loading...
NGNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NGNE vs. NRXS commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NGNE is a Buy and NRXS is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (NGNE: $15.46 vs. NRXS: $2.42)
Brand notoriety: NGNE and NRXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NGNE: 119% vs. NRXS: 236%
Market capitalization -- NGNE: $197.24M vs. NRXS: $14.07M
NGNE [@Biotechnology] is valued at $197.24M. NRXS’s [@Biotechnology] market capitalization is $14.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NGNE’s FA Score shows that 0 FA rating(s) are green whileNRXS’s FA Score has 0 green FA rating(s).

  • NGNE’s FA Score: 0 green, 5 red.
  • NRXS’s FA Score: 0 green, 5 red.
According to our system of comparison, both NGNE and NRXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NGNE’s TA Score shows that 5 TA indicator(s) are bullish while NRXS’s TA Score has 4 bullish TA indicator(s).

  • NGNE’s TA Score: 5 bullish, 4 bearish.
  • NRXS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NGNE is a better buy in the short-term than NRXS.

Price Growth

NGNE (@Biotechnology) experienced а +43.55% price change this week, while NRXS (@Biotechnology) price change was +49.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.04%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -12.57%.

Reported Earning Dates

NGNE is expected to report earnings on Nov 14, 2023.

NRXS is expected to report earnings on May 21, 2025.

Industries' Descriptions

@Biotechnology (+8.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NGNE($197M) has a higher market cap than NRXS($14.1M). NRXS YTD gains are higher at: 2.843 vs. NGNE (-32.371). NRXS has higher annual earnings (EBITDA): -8.02M vs. NGNE (-49.96M). NGNE has more cash in the bank: 139M vs. NRXS (261K). NRXS has less debt than NGNE: NRXS (477K) vs NGNE (14.5M). NRXS has higher revenues than NGNE: NRXS (2.46M) vs NGNE (925K).
NGNENRXSNGNE / NRXS
Capitalization197M14.1M1,397%
EBITDA-49.96M-8.02M623%
Gain YTD-32.3712.843-1,139%
P/E RatioN/AN/A-
Revenue925K2.46M38%
Total Cash139M261K53,257%
Total Debt14.5M477K3,040%
FUNDAMENTALS RATINGS
NGNE: Fundamental Ratings
NGNE
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NGNENRXS
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
NGNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GIDAX7.54N/A
N/A
Goldman Sachs Intl Eq Div & Prem A
HSZAX4.97N/A
N/A
NexPoint Climate Tech A
DURPX22.53N/A
N/A
DFA US Hi Relatv Profitability Instl
EMGEX6.85N/A
N/A
Emerging Markets Growth Fund F-3
SUIRX53.57N/A
N/A
DWS CROCI International R6

NGNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NGNE has been loosely correlated with BRNS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NGNE jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NGNE
1D Price
Change %
NGNE100%
+11.79%
BRNS - NGNE
51%
Loosely correlated
+8.02%
RNAZ - NGNE
48%
Loosely correlated
+1.96%
SNDX - NGNE
48%
Loosely correlated
+0.62%
ZNTL - NGNE
45%
Loosely correlated
+1.70%
MNMD - NGNE
44%
Loosely correlated
+5.00%
More

NRXS and

Correlation & Price change

A.I.dvisor tells us that NRXS and RZLT have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NRXS and RZLT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXS
1D Price
Change %
NRXS100%
+23.94%
RZLT - NRXS
25%
Poorly correlated
+27.65%
NGNE - NRXS
24%
Poorly correlated
+11.79%
PLUR - NRXS
23%
Poorly correlated
+40.83%
TCRT - NRXS
23%
Poorly correlated
+2.92%
ESLA - NRXS
22%
Poorly correlated
+16.10%
More